PCH
Polar Capital Holdings Portfolio holdings
AUM
$19.1B
This Quarter Return
+31.62%
1 Year Return
+55.52%
3 Year Return
+234.94%
5 Year Return
–
10 Year Return
–
AUM
$19.1B
AUM Growth
+$19.1B
(+16%)
Cap. Flow
-$459M
Cap. Flow
% of AUM
-2.41%
Top 10 Holdings %
Top 10 Hldgs %
32.59%
Holding
317
New
27
Increased
96
Reduced
114
Closed
36
Top Buys
| 1 |
Vertiv
VRT
|
$245M |
| 2 |
Advanced Micro Devices
AMD
|
$201M |
| 3 |
Broadcom
AVGO
|
$178M |
| 4 |
Seagate
STX
|
$158M |
| 5 |
Lumentum
LITE
|
$141M |
Top Sells
| 1 |
Alibaba
BABA
|
$162M |
| 2 |
CyberArk
CYBR
|
$143M |
| 3 |
Meta Platforms (Facebook)
META
|
$129M |
| 4 |
Elastic
ESTC
|
$124M |
| 5 |
Corning
GLW
|
$87.7M |
Sector Composition
| 1 | Technology | 46.54% |
| 2 | Financials | 18.05% |
| 3 | Healthcare | 13.07% |
| 4 | Communication Services | 10.56% |
| 5 | Consumer Discretionary | 6.02% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Globus Medical
GMED
$8.27B
| $62.9M | 0.33% | 1,065,564 +15,184 | +1% | +$896K |
|
77
Nuvalent
NUVL
$5.52B
| $62.3M | 0.33% | 816,087 -130,636 | -14% | -$9.97M |
|
78
Enliven Therapeutics
ELVN
$1.2B
| $61.2M | 0.32% | 3,050,294 +685,000 | +29% | +$13.7M |
|
79
Pinduoduo
PDD
$171B
| $60.2M | 0.31% | 574,820 -13,164 | -2% | -$1.38M |
|
80
Brown & Brown
BRO
$32B
| $59.9M | 0.31% | 540,000 +115,000 | +27% | +$12.8M |
|
81
Trip.com Group
TCOM
$48.2B
| $59.4M | 0.31% | 1,013,055 -24,713 | -2% | -$1.45M |
|
82
Grab
GRAB
$20.3B
| $56.9M | 0.3% | 11,318,184 +2,121,831 | +23% | +$10.7M |
|
83
Berkshire Hathaway Class B
BRK.B
$1.09T
| $56.8M | 0.3% | 116,992 -18,924 | -14% | -$9.19M |
|
84
Visa
V
$683B
| $55.9M | 0.29% | 157,399 -45,918 | -23% | -$16.3M |
|
85
Eli Lilly
LLY
$657B
| $55M | 0.29% | 70,602 -22,423 | -24% | -$17.5M |
|
86
Encompass Health
EHC
$12.3B
| $54.7M | 0.29% | 445,859 +443,600 | +19,637% | +$54.4M |
|
87
Hagerty
HGTY
$1.14B
| $53.8M | 0.28% | 5,319,027 +319,027 | +6% | +$3.23M |
|
88
Intuitive Surgical
ISRG
$170B
| $53.4M | 0.28% | 98,214 -149,089 | -60% | -$81M |
|
89
Scholar Rock
SRRK
$3.14B
| $53.1M | 0.28% | 1,500,000 -1,083,371 | -42% | -$38.4M |
|
90
Avidity Biosciences
RNA
$5.99B
| $50.3M | 0.26% | 1,770,387 -18,481 | -1% | -$525K |
|
91
Kaspi.kz JSC
KSPI
$17.9B
| $49.9M | 0.26% | 587,774 +381,332 | +185% | +$32.4M |
|
92
Mirum Pharmaceuticals
MIRM
$3.71B
| $49.6M | 0.26% | 975,000 -200,000 | -17% | -$10.2M |
|
93
Boston Scientific
BSX
$156B
| $48.8M | 0.26% | 454,257 -16,856 | -4% | -$1.81M |
|
94
Aflac
AFL
$57.2B
| $48.5M | 0.25% | 460,000 | – | – |
|
95
NewAmsterdam Pharma
NAMS
$2.71B
| $45.6M | 0.24% | 2,517,779 +267,779 | +12% | +$4.85M |
|
96
Roblox
RBLX
$86.4B
| $43.2M | 0.23% | 410,227 -41,165 | -9% | -$4.33M |
|
97
VTEX
VTEX
$742M
| $41.5M | 0.22% | 6,285,331 +841,855 | +15% | +$5.56M |
|
98
First American
FAF
$6.72B
| $41.4M | 0.22% | 675,000 | – | – |
|
99
Abbott
ABT
$231B
| $40.7M | 0.21% | 299,298 +64,294 | +27% | +$8.74M |
|
100
Ionis Pharmaceuticals
IONS
$6.79B
| $39.5M | 0.21% | +1,000,000 | New | +$39.5M |
|